美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LANGAR GLOBAL HEALTHTECH ETF

9.96

-0.0909-0.90%

盤後：10.000.0342+0.34%16:10 EDT

成交量：4,360

成交額：4.36萬

市值：229.10萬

市盈率：- -

高：10.02

開：10.02

低：9.96

收：10.05

52周最高：11.01

52周最低：7.97

股本：23.00萬

流通股本：23.00萬

量比：1.83

換手率：1.90%

股息：- -

股息率：- -

每股收益(LYR):1.91

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):5.22

資料載入中...

總覽公司新聞資訊公告

「大空頭」伯裏減持Veeva但仍看多，直言Snowflake「嚴重高估」

浩歐博(688656.SH)子公司獲得13項醫療器械註冊證

寧夏銀川市市場監管局多措並舉紮實推進新版醫療器械生產質量管理規範落地實施

中国质量新闻网

深入挖掘創新項目深圳市市場監督管理局組織開展2026年醫療器械重點創新項目路演遴選活動

深圳新闻网

九強生物：取得葉酸測定試劑盒醫療器械註冊證

新華醫療(600587.SH)產品獲得三類和二類醫療器械註冊證

新華醫療：獲得三類及二類醫療器械註冊證

國金證券：雙輪驅動醫療器械內外復甦聚焦創新與出海主線

港股異動 | 今海醫療科技(02225)升逾5% 上半年收益按年大幅增超1.3倍戰略重心轉向高附加值醫療器械賽道

單日暴漲177%的莫德納，對全球醫藥產業意味着什麼？

瑞思邁(RMD)股票9月1日盤中下跌3.25%：釋放什麼信號？

TradingKey中文

透景生命(300642.SZ)取得醫療器械註冊證

醫療器械迎業績拐點？512170成功收紅！AI4S帶火港股CXO，金斯瑞升逾7%！港股通醫療ETF華寶逆市上揚

賽諾醫療：子公司輸送型球囊擴張導管獲醫療器械註冊證

東方海洋(002086.SZ)：清道夫受體-A(SR-A)測定試劑盒獲得醫療器械註冊證

美年健康在寧波投資成立數智科技公司

更正-更新 1-葛蘭素史克將推進mRNA流感疫苗進入後期臨床試驗

步步高等成立商貿公司

美國醫療保險和醫療補助服務中心：將為阿肯色州農村醫院提供資金，用於升級救護車、拓展遠程醫療服務並安裝應急發電機

特朗普政府宣佈撥款1.493億美元，用於在阿肯色州農村地區擴展遠程醫療，並增加專科護理和預防性篩查的可及性。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/LGHT/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LGHT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGHT\",,,,,undefined,":{"symbol":"LGHT","market":"US","secType":"STK","nameCN":"LANGAR GLOBAL HEALTHTECH ETF","latestPrice":9.9608,"timestamp":1789761600000,"preClose":10.0517,"halted":0,"volume":4360,"hourTrading":{"tag":"盘后","latestPrice":9.995,"preClose":9.9608,"latestTime":"16:10 EDT","volume":6,"amount":59.7648,"timestamp":1789762204061,"change":0.0342,"changeRate":0.003433,"amplitude":0},"delay":0,"changeRate":-0.009043246416029082,"floatShares":230000,"shares":230000,"eps":0,"marketStatus":"休市中","change":-0.0909,"latestTime":"09-18 16:00:00 EDT","open":10.018,"high":10.018,"low":9.96,"amount":43578,"amplitude":0.00577,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"CBOE","adjPreClose":10.0517,"sharesOutstanding":400000,"nav":10.0444,"aum":2310212.36,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":9.995,"preClose":9.9608,"latestTime":"16:10 EDT","volume":6,"amount":59.7648,"timestamp":1789762204061,"change":0.0342,"changeRate":0.003433,"amplitude":0},"volumeRatio":1.8256426670445245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGHT\",,,,,undefined,":{"symbol":"LGHT","floatShares":230000,"roa":"--","roe":"--","lyrEps":1.906946,"volumeRatio":1.8256426670445245,"shares":230000,"dividePrice":0,"high":10.018,"amplitude":0.00577,"preClose":10.0517,"low":9.96,"week52Low":7.97,"pbRate":"--","week52High":11.01,"institutionHeld":0,"latestPrice":9.9608,"eps":0,"divideRate":0,"volume":4360,"delay":0,"ttmEps":0,"open":10.018,"prevYearClose":10.0748,"prevWeekClose":9.7424,"prevMonthClose":10.2195,"prevQuarterClose":8.5377,"fiveDayClose":9.7424,"twentyDayClose":10.06,"sixtyDayClose":8.1921},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LGHT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LGHT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LGHT\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LGHT\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664381095","title":"「大空頭」伯裏減持Veeva但仍看多，直言Snowflake「嚴重高估」","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381095","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381095?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 14:15","pubTimestamp":1788502538,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，知名投资人、电影《大空头》原型迈克尔·伯里重申对Veeva Systems的看多立场，但同时表示，在该股近期大幅上涨后，他已进行了减持。此外，伯里还批评Snowflake估值过高。伯里于今年4月披露持有Veeva头寸，作为其软件板块反弹策略的一部分，并于5月进一步加仓，当时称“Veeva仍然便宜”。Snowflake预计2027财年产品收入将同比增长36%至60.7亿美元，高于此前预期的58.4亿美元。Snowflake今年迄今上涨逾62%，市值超过1200亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491978.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4167","BK4613","BK4585","LU1989764664.SGD","LU1992135399.USD","LU0097036916.USD","BK4554","BK4581","BK4528","LU2250418816.HKD","BK4588","LU1852331112.SGD","SNOU","SNOY","DAT","LU2272731865.HKD","LU0889565833.HKD","VEEV","LU1992135472.HKD","LU0058720904.USD","BK4532","BK4548","LU0109392836.USD","BK4551","LU0266013472.USD","LU2272731782.SGD","LU1951198990.SGD","BK4534","LU0719512351.SGD","LU2290526834.HKD","WISE","XDAT","BK4607","LU2473716301.USD","LU2360106780.USD","LU1923623000.USD","LGHT","LU1861220033.SGD","LU1989764748.USD","LU1803068979.SGD","LU2322448791.USD","BK4504","EKG","SNOW","BK4559","LU2322448957.HKD","LU2272731600.USD","CLOU","BK4505","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664987559","title":"浩歐博(688656.SH)子公司獲得13項醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664987559","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664987559?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:04","pubTimestamp":1788429879,"startTime":"0","endTime":"0","summary":"智通财经APP讯，浩欧博(688656.SH)发布公告，公司全资子公司湖南浩欧博生物医药有限公司于近日获得13项由湖南省药品监督管理局核准签发的医疗器械注册证。上述医疗器械注册证的取得，进一步丰富了公司化学发光平台检测菜单，有助于提升公司市场综合竞争力，对公司及子公司的可持续性发展将产生积极影响和促进作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LNGR","688656","159883","LGHT","MDEV","BK1574","09996","HART","GDOC","BK1583","BK1100","MEDX","IEIH","BK0239","RSPH","PTH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827350","title":"寧夏銀川市市場監管局多措並舉紮實推進新版醫療器械生產質量管理規範落地實施","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827350","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827350?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 15:48","pubTimestamp":1788421680,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 2025年修订的新版《医疗器械生产质量管理规范》将于2026年11月正式施行。下一步，银川市市场监管局将全面梳理前期新规衔接推进情况及企业预检查问题台账，细化阶段性工作目标和推进举措，持续跟进企业问题整改落实进度，督促企业按期完成整改提升工作，确保新版《医疗器械生产质量管理规范》在该市平稳落地、有序施行，持续规范医疗器械生产秩序，全力守护群众用械安全。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-03/doc-iniqpvfw2067175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","LGHT","GDOC","AGNG","159883","BK1583","MDEV","PTH","RSPH","09996","IEIH","MEDX","HART","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811819","title":"深入挖掘創新項目 深圳市市場監督管理局組織開展2026年醫療器械重點創新項目路演遴選活動","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811819","media":"深圳新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811819?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 19:25","pubTimestamp":1788348300,"startTime":"0","endTime":"0","summary":"深圳市市场监督管理局已连续两年开展医疗器械重点创新项目路演遴选活动。2026年深圳市市场监督管理局将延续去年经验做法，为遴选出的项目提供快速链接服务，助力项目加快注册审批、实现成果转化。下一步，深圳市市场监督管理局将根据本次路演遴选结果，向国家药监局、省药监局及产业部门精准推荐重点服务项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-02/doc-iniqmwqu2753585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","LNGR","09996","GDOC","BK1583","AGNG","IEIH","BK1100","BK1574","HART","RSPH","PTH","MDEV","MEDX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894050","title":"九強生物：取得葉酸測定試劑盒醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894050","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894050?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:54","pubTimestamp":1788335696,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","MEDX","RSPH","LNGR","PTH","HART","MDEV","AGNG","LGHT","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664489420","title":"新華醫療(600587.SH)產品獲得三類和二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664489420","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664489420?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:44","pubTimestamp":1788335097,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华医疗 发布公告，公司近日收到国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》、子公司新华手术器械有限公司于近日收到山东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》。该产品取得注册证后，不仅丰富了公司在微创腔镜领域的产品矩阵，也提升了在胸腔镜手术领域的综合竞争力，有助于扩大市场覆盖范围并增强品牌影响力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490883.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","HART","MEDX","BK0188","IEIH","RSPH","BK1583","BK1574","PTH","GDOC","LGHT","BK0251","BK0028","159883","600587","LNGR","AGNG","09996","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664489426","title":"新華醫療：獲得三類及二類醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664489426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664489426?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:44","pubTimestamp":1788335042,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","RSPH","MEDX","LNGR","AGNG","MDEV","IEIH","HART","GDOC","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894673","title":"國金證券：雙輪驅動醫療器械內外復甦 聚焦創新與出海主線","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894673","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894673?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 15:25","pubTimestamp":1788333958,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国金证券发布研报称，医疗器械板块当前投资应紧扣“出海拓增量、创新守利润”的双轮驱动逻辑，同时把握国内需求复苏节奏。出海能有效分散集采风险，打开成长天花板，而持续的高强度研发投入则是维持高毛利率、抵御价格战的关键护城河。国金证券主要观点如下：医疗设备收入端同比稳定增长，毛利率略有承压。医疗耗材收入增速快速恢复，毛利率显著提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600109","LGHT","MDEV","BK0188","PTH","09996","LNGR","RSPH","BK0183","HART","159883","BK1583","AGNG","MEDX","BK0201","BK0276","BK1574","BK0012","BK0028","GDOC","BK1100","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664899822","title":"港股異動 | 今海醫療科技(02225)升逾5% 上半年收益按年大幅增超1.3倍 戰略重心轉向高附加值醫療器械賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664899822","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664899822?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 14:04","pubTimestamp":1788329049,"startTime":"0","endTime":"0","summary":"消息面上，近期，今海医疗科技披露2026年中期业绩。2026年上半年，集团实现收益3402.1万新加坡元，同比大幅增长134.16%，展现出强劲的销售增长动能。业务端，2026年上半年，公司收入结构显著优化，战略重心已成功从传统劳务服务转向高附加值的医疗器械赛道。继2025年医疗器械销售收益实现良好增长后，2026年上半年该业务收益同比激增301.5%，达到2542.7万新加坡元，可持续增长动力充足。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LGHT","MDEV","PTH","KCAI","09996","LNGR","RSPH","BK4585","VXUS","BK4588","HART","159883","BK1583","AGNG","MEDX","02225","BK1574","BK1150","GDOC","BK1100","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664589566","title":"單日暴漲177%的莫德納，對全球醫藥產業意味着什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589566","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589566?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 12:10","pubTimestamp":1788322216,"startTime":"0","endTime":"0","summary":"引发一切的，是当天莫德纳与默沙东联合公布的一份三期临床试验顶线结果。177%不是一天涨出来的要更进一步理解此次大涨，需要先理解市场之前对莫德纳的评判逻辑。默沙东为此等了十年，2016年签下合作协议并支付2亿美元首付款，2018年追加1.25亿美元战略投资，2022年正式行使共同开发选择权。8月20日下跌23.55%之后，莫德纳并没有跌回去。这里值得单独一提的是8月20日涨幅最大的云顶新耀，这","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788143888266092586","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SG9999002224.SGD","LU2125154778.USD","LU1037948541.HKD","SG9999014567.USD","LU0868494708.USD","LU1571399168.USD","LU2461242641.AUD","SG9999015341.SGD","LU0980610538.SGD","LU1057294990.SGD","MRK","BK4551","BK4585","IXJ","MRNY","LU2491050071.SGD","LU2491049909.HKD","LU2357627491.SGD","LU2125154935.USD","LU1923622614.USD","IE000M9KFDE8.USD","LU0320765646.SGD","LU1023059063.AUD","VHT","BK4501","FTXH","LU1917777945.USD","LU1066051225.USD","LU0124676726.USD","SG9999015358.SGD","IE00BSNM7G36.USD","IE00B1BXHZ80.USD","PPH","SG9999013999.USD","MRNX","BNTX","LU0477156953.USD","LU1983299246.USD","LU1201861249.SGD","LU2023250843.SGD","BK4548","TRUH","IE0009355771.USD","LU1934455194.USD","BK4532","LU0965508806.USD","LU0648001328.SGD","LU0098860793.USD","BK4568","LU1037948897.HKD","SG9999014559.SGD","LGHT","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1116320901.HKD","SG9999001440.SGD","BK4533","BK4516","LU2361045086.USD","LU1066051498.USD","IE00BFTCPJ56.SGD","LU2125909247.SGD","IYH","LU2433249047.HKD","LU2089984988.USD","LU1934455277.USD","WDNA","LU2360032135.SGD","LU2125909593.SGD","LU0130517989.USD","LU0203345920.USD","IE00BBT3K403.USD","LU1585245621.USD","LU0122379950.USD","LU0265550946.USD","LU1061106388.HKD","SG9999001176.SGD","LU1929549753.HKD","LU0689626769.HKD","LU2491050154.USD","SG9999001176.USD","BK4535","IHE","IE00BLSP4452.SGD","LU0942090050.USD","LU1430594728.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4007","LU0266013472.USD","BK4588","LU1116320737.USD","LU0203347892.USD","BK1161","BK4559","JDOC","LU1035773651.USD","LU1699723380.USD","LU2106854487.HKD","LU0289739699.SGD","LU0070302665.USD","BMED","LU0965509283.SGD","LU0320765489.SGD","LU2023250504.SGD","LU0234572021.USD","LU1093756325.SGD","SGXZ57979304.SGD","LU0265550359.USD","LU1934455863.HKD","RXL","LU0823416689.USD","LU1941712264.USD","LU2361044949.HKD","PAWZ","LU1066051811.HKD","LU0211331839.USD","LU0238689110.USD","SG9999014575.USD","IE0002141913.USD","IE00BLSP4239.USD","LU1066053197.SGD","SG9999002232.USD","LU1162221912.USD","LU0106261372.USD","01952","FHLC","LU0006306889.USD","XLV","HRTS","BK1574","LU0130102774.USD","GNOM","IE00BN8TJ469.HKD","IDNA","LU0058720904.USD","LU1032466523.USD","GDOC","LU0868494617.USD","LU0965509101.SGD","LU2112291526.USD","LU2361044865.SGD","LU0985320562.USD","LU1291159041.SGD","LU1941712348.USD","SG9999014542.SGD","LU1989772923.USD","LU1093756168.USD","LU0859254822.USD","BK4550","BK4139","MRNA","LU0208291251.USD","IE00BJT1NW94.SGD","LU2324357040.USD","BK4534","LU0432979614.USD","LU1974910355.USD","LU0965509010.AUD","LU1989771016.USD","LU1989772840.SGD","LU0861579265.USD","BK1583","LU1069347547.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852863","title":"瑞思邁(RMD)股票9月1日盤中下跌3.25%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852863","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664852863?lang=zh_tw&edition=fundamental","pubTime":"2026-09-02 01:16","pubTimestamp":1788282992,"startTime":"0","endTime":"0","summary":"• 瑞思迈因 Astral 呼吸机暂停销售和战略产品组合调整而面临波动。\n• 管理层表示，尽管围绕 GLP-1 疗法的讨论仍在持续，但睡眠呼吸暂停市场的渗透率依然较低。\n• 该公司全年营收达到 56.5 亿美元，净利润达 15.2 亿美元。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262144537-market-movers-rmd-20260901","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5TLWC47.USD","BK4504","LU2008162690.USD","BK7501","LU2177674079.SGD","RMD.AU","BK7007","BK4588","LGHT","BK4548","BK4585","BK4082","LU0170899867.USD","BK4567","RMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855470","title":"透景生命(300642.SZ)取得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855470","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855470?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:34","pubTimestamp":1788262475,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)发布公告，公司及控股子公司上海脉示生物技术有限公司于近日取得上海市药品监督管理局颁发的6项医疗器械注册证。上述医疗器械注册证的取得，丰富了公司及子公司在多个技术平台的产品线布局，进一步完善公司在非肿瘤检测领域的业务布局，有利于提升公司整体品牌影响力和市场拓展能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","LNGR","MEDX","AGNG","159883","BK0046","09996","PTH","GDOC","HART","BK1100","BK0239","MDEV","RSPH","300642","IEIH","BK1574","LGHT","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855519","title":"醫療器械迎業績拐點？512170成功收紅！AI4S帶火港股CXO，金斯瑞升逾7%！港股通醫療ETF華寶逆市上揚","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855519","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855519?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:12","pubTimestamp":1788261120,"startTime":"0","endTime":"0","summary":"9月1日，A股港股医疗板块逆市表现，医疗ETF华宝、港股通医疗ETF华宝等相关品种热度再升温。医疗器械方面，英科医疗上半年营收、净利双增，迈瑞医疗利润降幅显著收窄至5.4%，联影医疗营收同比增长17%。中信建投研报指出，医疗器械行业迎来业绩修复拐点，2026Q2归母净利润实现四年首正增长，板块整体企稳回升。聚焦医疗器械+医疗服务，CXO含量超30%，兼顾脑机接口、AI医疗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-01/doc-iniqipis4811448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["RSPH","LNGR","IEIH","AGNG","CXO","BK4585","GDOC","MEDX","VXUS","WX","LGHT","BK4588","PTH","MDEV","KCAI","HART","BK1574","512170","BK1100","09996","FLHK","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664858778","title":"賽諾醫療：子公司輸送型球囊擴張導管獲醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664858778","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664858778?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 18:35","pubTimestamp":1788258920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","LGHT","IEIH","MDEV","GDOC","AGNG","PTH","MEDX","HART","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831017","title":"東方海洋(002086.SZ)：清道夫受體-A(SR-A)測定試劑盒獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831017","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831017?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 16:03","pubTimestamp":1788249802,"startTime":"0","endTime":"0","summary":"智通财经APP讯，东方海洋(002086.SZ)发布公告，公司全资子公司艾维可生物科技有限公司自主研发的清道夫受体-A(SR-A)测定试剂盒(磁微粒化学发光法)于近日取得了山东省药品监督管理局的注册批准，获得医疗器械注册证。该产品用于体外定性测定人体血清、血浆中的清道夫受体-A(SR-A)。上述产品获准上市，进一步丰富了艾维可生物科技有限公司在临床检测领域的产品线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","RSPH","LNGR","IEIH","BK0213","BK1100","159883","09996","BK0092","BK1574","HART","MEDX","GDOC","BK0046","002086","PTH","LGHT","AGNG","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831126","title":"美年健康在寧波投資成立數智科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831126","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664831126?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 15:50","pubTimestamp":1788249053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HART","MDEV","MEDX","AGNG","IEIH","LNGR","LGHT","GDOC","PTH","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664835279","title":"更正-更新 1-葛蘭素史克將推進mRNA流感疫苗進入後期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2664835279","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664835279?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 14:29","pubTimestamp":1788244147,"startTime":"0","endTime":"0","summary":"更正-更新 1-葛兰素史克将推进mRNA流感疫苗进入后期临床试验更正第4段内容，澄清GSK计划于2026年启动20多项晚期临床试验路透9月1日-葛兰素史克GSK.L周二表示，将把其基于mRNA的季节性流感疫苗候选药物推进至后期临床试验，此前中期试验数据显示，该疫苗在年轻和老年受试者中产生的免疫应答强于目前获批的标准剂量和高剂量疫苗。GSK计划于本月启动该mRNA流感疫苗候选物的后期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T0I2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","SGXZ57979304.SGD","BK4551","LU1400636657.SGD","MRNA","LU0321505439.SGD","IE00BQJZX424.USD","LU0971552673.USD","LU0161305163.EUR","LU1228905037.USD","WDNA","BK4534","SG9999001176.USD","GNOM","LU0225283273.USD","LU0306807586.USD","LU0575583348.USD","LU1064927863.SGD","IE00B3T34201.USD","BK4533","LU2089984988.USD","BK4588","LGHT","LU0557290698.USD","LU0203345920.USD","LU1302929846.USD","LU0306806265.USD","LU0987226296.USD","IDNA","LU1645745479.HKD","LU1015430645.USD","LU1481600234.SGD","LU0289739699.SGD","LU0545562505.USD","LU1309081286.SGD","LU1098665638.USD","BK5011","LU1228905540.USD","BK4139","LU1983299246.USD","GSK.UK","LU1400636491.USD","SG9999001176.SGD","MRNY","BK4548","MRNX","BK4532","SG9999013999.USD","LU2646069778.SGD","LU1481599808.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880657","title":"步步高等成立商貿公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880657","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664880657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 11:46","pubTimestamp":1788234379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LGHT","MDEV","GDOC","PTH","LNGR","MEDX","HART","RSPH","AGNG","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008470","title":"美國醫療保險和醫療補助服務中心：將為阿肯色州農村醫院提供資金，用於升級救護車、拓展遠程醫療服務並安裝應急發電機","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008470","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664008470?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 02:18","pubTimestamp":1788200331,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","LU0390134368.USD","UNHU","LU1983260115.SGD","EKG","GDOC","HUM","LU0208291251.USD","RSPH","UNHW","LU0320765489.SGD","LU0266013472.USD","IEHS","BK4533","LU0211331839.USD","LU1093756168.USD","SG9999014021.USD","FDHT","LU0417517546.SGD","BK4588","LGHT","BK4585","SG9999014013.SGD","IEIH","LU0238689110.USD","LU0256863811.USD","BK4566","SG9999014005.SGD","HTEC","UNHG","HEAL","IHF","LU1093756325.SGD","BK4154","UN","LU0170899867.USD","BMED","LU0348723411.USD","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811000","title":"特朗普政府宣佈撥款1.493億美元，用於在阿肯色州農村地區擴展遠程醫療，並增加專科護理和預防性篩查的可及性。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811000","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811000?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 02:17","pubTimestamp":1788200232,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","BMED","HTEC","GDOC","LGHT","HEAL","FDHT","EKG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}